USANA Health Sciences, Inc.
USNA
$27.18
$0.080.30%
NYSE
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -34.11% | -9.15% | -13.12% | -5.09% | -8.02% |
| Total Depreciation and Amortization | 8.99% | 2.12% | -1.07% | -3.68% | -4.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -32.66% | -34.94% | -21.77% | -16.10% | 16.86% |
| Change in Net Operating Assets | 53.56% | 52.04% | -58.60% | -355.42% | -3,731.52% |
| Cash from Operations | -13.66% | -4.53% | -19.62% | -22.20% | -32.01% |
| Capital Expenditure | 30.50% | -49.16% | -16.45% | -45.44% | -39.37% |
| Sale of Property, Plant, and Equipment | 326.67% | 312.50% | -70.59% | 350.00% | 114.29% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -89.82% | -89.82% | -89.82% | -11.54% | -45.03% |
| Cash from Investing | -1,679.46% | -92.49% | -43.04% | 9.29% | 3.19% |
| Total Debt Issued | 1,436.12% | 97.47% | 18.64% | 107.90% | -85.98% |
| Total Debt Repaid | -95.60% | -96.40% | -18.08% | 93.18% | 93.18% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 13.78% | 13.46% | -681.00% | -624.46% | 51.17% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | 100.00% | -- |
| Cash from Financing | 167.10% | 15.46% | -604.23% | -67.84% | 52.68% |
| Foreign Exchange rate Adjustments | -147.42% | 277.18% | 68.34% | 43.56% | 81.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -454.76% | -2.59% | -53.22% | -42.35% | -12.04% |